1st Sep 2020 7:00 am |
RNS |
Imfinzi approved in EU for small cell lung cancer |
1st Sep 2020 7:00 am |
RNS |
Farxiga reduces CKD progression and risk of death |
25th Aug 2020 7:00 am |
RNS |
Ph I trial begins for COVID-19 monoclonal antibody |
21st Aug 2020 7:00 am |
RNS |
Imfinzi approved in Japan for SCLC |
18th Aug 2020 7:00 am |
RNS |
Imfinzi US Priority Review; four-week, fixed dose |
4th Aug 2020 7:00 am |
RNS |
AstraZeneca prices a $3bn bond issue |
3rd Aug 2020 3:00 pm |
RNS |
Total Voting Rights |
30th Jul 2020 7:25 am |
RNS |
Tagrisso US BTD for EGFRm adjuvant lung cancer |
30th Jul 2020 7:18 am |
RNS |
AZN: H1 2020 results |
29th Jul 2020 7:00 am |
RNS |
Board Committee Changes |
28th Jul 2020 7:00 am |
RNS |
Farxiga DAPA-CKD trial met all endpoints |
27th Jul 2020 7:10 am |
RNS |
Calquence receives positive CHMP opinion for CLL |
27th Jul 2020 7:05 am |
RNS |
Imfinzi recommended for EU approval in SCLC |
27th Jul 2020 7:00 am |
RNS |
AstraZeneca enters collaboration in oncology |
24th Jul 2020 7:00 am |
RNS |
Breztri Aerosphere approved in the US for COPD |
22nd Jul 2020 3:00 pm |
RNS |
Holding(s) in Company |
22nd Jul 2020 3:00 pm |
RNS |
Holding(s) in Company |
21st Jul 2020 3:00 pm |
RNS |
Holding(s) in Company |
21st Jul 2020 3:00 pm |
RNS |
Holding(s) in Company |
20th Jul 2020 2:41 pm |
RNS |
COVID-19 vaccine Phase I/II showed immune response |
16th Jul 2020 7:00 am |
RNS |
Director Declaration |
9th Jul 2020 7:00 am |
RNS |
Brilinta granted US FDA Priority Review for stroke |
8th Jul 2020 7:00 am |
RNS |
Lynparza approved in the EU for pancreatic cancer |
1st Jul 2020 3:00 pm |
RNS |
Total Voting Rights |
30th Jun 2020 3:00 pm |
RNS |
Director/PDMR Shareholding |
30th Jun 2020 7:00 am |
RNS |
Selumetinib granted Japan orphan drug designation |
17th Jun 2020 3:03 pm |
RNS |
Holding(s) in Company |
17th Jun 2020 3:00 pm |
RNS |
Holding(s) in Company |
15th Jun 2020 7:00 am |
RNS |
Agreement to Supply Europe with COVID-19 Vaccine |
11th Jun 2020 7:00 am |
RNS |
EMTN Programme Routine Technical Update |
1st Jun 2020 3:00 pm |
RNS |
Block listing Interim Review |
1st Jun 2020 3:00 pm |
RNS |
Total Voting Rights |
1st Jun 2020 7:00 am |
RNS |
Lynparza EU CHMP opinion in pancreatic cancer |
1st Jun 2020 7:00 am |
RNS |
Brilinta obtains additional US approval |
29th May 2020 4:41 pm |
RNS |
Second Price Monitoring Extn |
29th May 2020 4:35 pm |
RNS |
Price Monitoring Extension |
29th May 2020 1:00 pm |
RNS |
Imfinzi sustained overall survival in CASPIAN |
29th May 2020 1:00 pm |
RNS |
Enhertu DESTINY-Gastric01 results from ASCO 2020 |
29th May 2020 7:00 am |
RNS |
Tagrisso unprecedented adjuvant lung cancer data |
26th May 2020 10:30 am |
RNS |
Director/PDMR Shareholding |